Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).
about
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screensAcid Stability of the Hemagglutinin Protein Regulates H5N1 Influenza Virus PathogenicityComparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passageIdentification of traditional medicinal plant extracts with novel anti-influenza activityTwo Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyViral factors in influenza pandemic risk assessment.Pseudotype-based neutralization assays for influenza: a systematic analysis.6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesViral fusion efficacy of specific H3N2 influenza virus reassortant combinations at single-particle level.Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.Imaging of influenza virus sialidase activity in living cells.Characterization of the anti-influenza activity of the Chinese herbal plant Paeonia lactiflora.High-throughput neuraminidase substrate specificity study of human and avian influenza A virusesInfluenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion.Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrateCell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza.Amino acid substitutions in the neuraminidase protein of an H9N2 avian influenza virus affect its airborne transmission in chickens.The cytoplasmic tail domain of influenza B virus hemagglutinin is important for its incorporation into virions but is not essential for virus replication in cell culture in the presence of compensatory mutations.Acquisition of a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular cleavage of an H7N7 influenza virus hemagglutinin.The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replicationAn extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage FunctionEthanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase.Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.Alterations in hemagglutinin receptor-binding specificity accompany the emergence of highly pathogenic avian influenza viruses.A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.Necrotic Response to Low Pathogenic H9N2 Influenza Virus in Chicken Hepatoma Cells.In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses.Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Conformational stability of the hemagglutinin of H5N1 influenza A viruses influences susceptibility to broadly neutralizing stem antibodies.Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.
P2860
Q26852062-07771B91-5AD9-4FE3-A5B0-E16281D0F439Q27676000-DF8AB0FD-3882-4778-B45C-91961D9F8B0AQ28534776-A875EA07-0E65-4298-8591-AE9DB1555CF9Q28535461-B2667DB9-EF2E-4797-BFD1-D073E7DF9546Q28552195-FBFABECE-39D6-4443-A8BC-D9FD8B040E12Q30275435-685C9B4D-E0D3-4EBF-8DC0-DC6016029740Q30374662-CA74EDA1-1441-493B-9A49-80142FFEA70BQ30376631-9903FD54-A622-4132-9162-BF5F1FA26305Q30377784-F7593659-ED3D-44CC-A6A4-FF2EB977BFE1Q30386823-04E2745E-19EE-40EF-9ACA-B39617D50A9CQ30394213-268C5056-4CC9-4715-BC2D-EEF04357C77BQ30400817-13C3A39A-39E2-481D-9BB2-26A347021C26Q30404888-2FEAA00C-23D0-42AC-B6E2-51D4132A07AFQ30432293-8758B9F8-2300-4D97-8E95-B30B1FEA52F0Q33554574-FD435560-16F9-444C-A003-FC55C3BFCCE3Q33584810-5D11B486-4E76-4E0E-88BB-EA1067960A24Q33876089-D0F244D6-8853-42F9-8C67-6FADEE336F23Q34360974-C79540E2-DA82-46E6-878D-39A5685CCED9Q34971083-764BE2DD-1CF6-4B9C-922B-00E216C0C461Q35014925-F048E3C8-A586-4E0A-8AD2-F8714BD9DDA8Q35496878-74680884-C71C-4AA0-A0A7-11FA314C6551Q36363199-BEC8D591-D52A-48E6-AD6D-033EE5B6B141Q36765363-B800BEDF-F33A-4E23-B9FF-88F29E2C5B47Q36947814-8AB57D31-B8F3-4025-99B6-03BFEF1CBE95Q37379463-54B81020-FB0B-4588-AA6C-EB919A1C6626Q37560736-B8D17223-5ED1-4C05-B865-7968D4BBB8DEQ37723367-2D9DA1A3-4AFA-40DE-BD83-8379327912F8Q37866816-B620B1C4-6990-47FE-BD62-1E8CF9256796Q38300640-487798D0-D7ED-46DB-806C-386F80D863FBQ38802959-4A089CED-65B5-48AD-8E7A-0FCFC75B4104Q38897653-E1F59E6D-F924-4CCC-899E-7240B4B4D0EDQ38960185-CF9E7C31-1197-415F-A0F1-A1613D0AAFF5Q39271411-94922F97-FD17-4CFA-9701-BBE7C98E1DEFQ39336302-800BE2A6-5715-4959-A274-237849FB8F13Q40198479-F049C8EA-C8C1-44D9-8C43-1C5D3014BB49Q47426452-E0F2CFD2-A0EA-4DE2-AC77-AFE612CDF064Q49829189-4AABF9B3-7D15-40E6-8B66-89A18DDB05F3Q52609074-3A2DD992-17BA-4594-AF49-133E59765A54Q52625012-CA643E99-9379-4FDE-A8C9-0CC95377A0F3Q54230830-352D0180-46E2-4A0B-94AA-9C9ED5132A9D
P2860
Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@ast
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@en
Enhancement of the influenza A hemagglutinin
@nl
type
label
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@ast
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@en
Enhancement of the influenza A hemagglutinin
@nl
prefLabel
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@ast
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@en
Enhancement of the influenza A hemagglutinin
@nl
P2093
P2860
P50
P1433
P1476
Enhancement of the influenza A ...... the viral neuraminidase (NA).
@en
P2093
Dominic Dwyer
Sébastien Wurtzer
P2860
P356
10.1371/JOURNAL.PONE.0008495
P407
P50
P577
2009-12-30T00:00:00Z